Evaluating DCIS treatments — do you know your “survival” statistics?
“There is strong evidence that treatment of DCIS in most women has no clear effect on mortality reduction.” – Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS) “Risk of development of metastases and/or death in a patient diagnosed with pure DCIS is very low (<1%).” Ductal Carcinoma-In-Situ of the Breast […]
Dr. Esserman Touts Tamoxifen
Armed with a list of questions, I enthusiastically flew to San Francisco to hear what Dr. Esserman had to say about my DCIS situation and her recommendations for risk reduction and monitoring. After waiting 2 hours in the lobby and 1.5 hours in the exam room, Dr. Esserman finally greeted me. (I learned this extremely […]